Preoperative value of CA 125 as a reflection of tumor grade in epithelial ovarian cancer

Gynecologic Oncology

Volumn 63, Issue 2, 1996, Pages 166-172

  But, Igor ^a   Gorišek, Borut ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SCREENING; DECISION MAKING; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0030298097     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0301     Document Type: Article

References (29)

1. 1. Tortolero-Luna. Epidemiology and screening of ovarian cancer, in Update on epithelial ovarian cancer (D. M. Gershenson, Ed.), Obstet. Gynecol. Clin. North Am. 21, 1-23 (1994).
2. 2. Barber, H. Ovarian carcinoma: Etiology, diagnosis and treatment, 3rd ed., Springer-Verlag, New York, pp. 2-3 (1993).
3. 3. Burghardt, E., Lahousen, M., Stettner, H., and Petru, E. Results: Calculating survival rates, in Surgical gynecologic oncology (E. Burghardt, Ed.), Thieme, Stuttgart, New York, pp. 474-487 (1993).
4. 4. Baker, V. V. Molecular biology and genetics of epithelial ovarian cancer, in Update on epithelial ovarian cancer (D. M. Gershenson, Ed.), Obstet. Gynecol. Clin. North. Am. 21, 25-40 (1994).
5. 5. Bast, R. C., Jacobs, I., and Berchuck, A. Malignant transformation of ovarian epithelium, J. Natl. Cancer. Inst. 84, 556-558 (1992).
6. 6. Bast, R. C., Feeney, M., Lazarus, H., and Knapp, R. C. Reactivity of a monoclonal antibody with human ovarian carcinoma, J. Clin. Invest. 68, 1331-1337 (1981).
7. 7. Kabawat, S. E., Bast, R. C., Welch, W. R., and Knapp, R. C. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types, Am. J. Clin. Pathol. 79, 98-104 (1983).
8. 8. Brioschi, P. A., and Irion, O. Serum CA 125 in epithelial ovarian cancer: A longitudinal study, Br. J. Obstet. Gynaecol. 94, 193-207 (1987).
9. 9. Welander, C. E. What do CA 125 and other antigens tell us about ovarian cancer biology, Acta Obstet. Gynecol. Scand. 71, 85-93 (1992).
10. 10. Tholander, B., Taube, A., and Lindgren, A. Pretreatment serum levels of CA 125, carcinoembryonic antigen, tissue polypeptide antigen and placental alkaline phosphatase in patients with ovarian carcinoma: Influence of histological type, grade of differentiation and clinical stage of disease, Gynecol. Oncol. 39, 26-33 (1990).
11. 11. Cruickshank, D. J., and Fullerton, W. T. The clinical significance of preoperative serum CA 125 in ovarian cancer, Br. J. Obstet. Gynaecol. 94, 692-698 (1987).
12. 12. Patsner, B., and Mann, W. J. The value of preoperative serum CA 125 levels in patients with a pelvic mass, Am. J. Obstet. Gynecol. 159, 873-876 (1988).
13. 13. Zurawski, V. R., Knapp, R. C., and Einhorn, N. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma, Gynecol. Oncol. 30, 7-14 (1988).
14. 14. International Federation of Gynecology and Obstetrics (FIGO). Changes in gynecologic cancer staging by the International Federation of Gynecology and Obstetrics, Am. J. Obstet. Gynecol. 162, 610 (1990).
15. 15. Creasman, W. T. New gynecologic cancer staging, Obstet. Gynecol. 75, 287-288 (1990).
16. 16. Breitenecker, G., Neunteufel, W., Bieglmayer, C., Koelbl, H., and Schieder, K. Comparison between tissue and serum content of CA 125, CA 19-9, and carcinoembryonic antigen in ovarian tumors, Int. J. Gynecol. Pathol. 8, 97-102 (1989).
17. 17. Vergote, I. B., and Boermer, O. P. Evaluations of serum CA 125 levels in the monitoring of ovarian cancer, Am. J. Obstet. Gynecol. 157, 88-92 (1987).
18. 18. Patsner, B., and Day, T. G. Predictive value of CA 125 levels in advanced ovarian cancer, Am. J. Obstet. Gynecol. 156, 440-441 (1987).
19. 19. Hempling, R. E. Tumor markers in epithelial ovarian cancer: Clinical applications, in Update on epithelial ovarian cancer (D. M. Gershenson, Ed.), Obstet. Gynecol. Clin. North. Am. 21, 41-61 (1994).
20. 20. Malkasian, G. D., Knapp, R. C., and Lavin, P. T. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: Discrimination of benign from malignant disease, Am. J. Obstet. Gynecol. 2, 341-346 (1988).
21. 21. Westhoff, C., Gollub, E., Patel, J., and Bast, R. The CA 125 levels in menopausal women, Obstet. Gynecol. 76, 428-431 (1990).
22. 22. Malkasian, G. D., and Melton, J. Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary, Am. J. Obstet. Gynecol. 149, 274-284 (1984).
23. 23. Sevelda, P., Schemper, M., and Spona, J., CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer, Am. J. Obstet. Gynecol. 161, 1213-1216 (1989).
24. 24. Malkasian, G. D. Editorial, Gynecol. Oncol. 44, 205-206 (1992).
25. 25. Makar, A., Kristensen, G. B., and Kaern, J. Prognostic value of pre-and postoperative serum CA 125 levels in ovarian cancer: New aspects and multivariate analysis, Obstet. Gynecol. 79, 1002-1010 (1992).
26. 26. Bast, R. C., Niloff, J. M., and Klug, T. L. Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9 and carcinoembryonic antigen, Am. J. Obstet. Gynecol. 149, 553-559 (1984).
27. 27. Buller, R. E., and Berman, M. L. CA 125 regression: A model for ovarian cancer response, Am. J. Obstet. Gynecol. 165, 360-367 (1991).
28. 28. Niloff, J. M., Knapp, R. C., and Bast, R. C. The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer, Am. J. Obstet. Gynecol. 155, 56-60 (1986).
29. 29. But, I. Preoperativna analiza CA 125 pri invazivnem ovarijskem karcinomu: Magistrskanaloga. Medicinska fakulteta Univerza v Ljubljani, Ljubljana (1994).